Pongratz D - Search Results

1

Creatine monohydrate in myotonic dystrophy: a double-blind, placebo-controlled clinical study.

Walter MC, Reilich P, Lochmüller H, Kohnen R, Schlotter B, Hautmann H, Dunkl E, Pongratz D, Müller-Felber W. Walter MC, et al. Among authors: pongratz d. J Neurol. 2002 Dec;249(12):1717-22. doi: 10.1007/s00415-002-0923-x. J Neurol. 2002. PMID: 12529796 Clinical Trial.

2

Muscle pathology in 57 patients with myotonic dystrophy type 2.

Schoser BG, Schneider-Gold C, Kress W, Goebel HH, Reilich P, Koch MC, Pongratz DE, Toyka KV, Lochmüller H, Ricker K. Schoser BG, et al. Muscle Nerve. 2004 Feb;29(2):275-81. doi: 10.1002/mus.10545. Muscle Nerve. 2004. PMID: 14755494

3

The long-term outcome of anti-Jo-1-positive inflammatory myopathies.

Späth M, Schröder M, Schlotter-Weigel B, Walter MC, Hautmann H, Leinsinger G, Pongratz D, Müller-Felber W. Späth M, et al. Among authors: pongratz d. J Neurol. 2004 Jul;251(7):859-64. doi: 10.1007/s00415-004-0449-5. J Neurol. 2004. PMID: 15258790

4

High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled study.

Walter MC, Lochmüller H, Toepfer M, Schlotter B, Reilich P, Schröder M, Müller-Felber W, Pongratz D. Walter MC, et al. Among authors: pongratz d. J Neurol. 2000 Jan;247(1):22-8. doi: 10.1007/s004150050005. J Neurol. 2000. PMID: 10701893 Clinical Trial.

5

Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study.

Walter MC, Lochmüller H, Reilich P, Klopstock T, Huber R, Hartard M, Hennig M, Pongratz D, Müller-Felber W. Walter MC, et al. Among authors: pongratz d. Neurology. 2000 May 9;54(9):1848-50. doi: 10.1212/wnl.54.9.1848. Neurology. 2000. PMID: 10802796 Clinical Trial.

6

A placebo-controlled crossover trial of creatine in mitochondrial diseases.

Klopstock T, Querner V, Schmidt F, Gekeler F, Walter M, Hartard M, Henning M, Gasser T, Pongratz D, Straube A, Dieterich M, Müller-Felber W. Klopstock T, et al. Among authors: pongratz d. Neurology. 2000 Dec 12;55(11):1748-51. doi: 10.1212/wnl.55.11.1748. Neurology. 2000. PMID: 11113239 Clinical Trial.

7

Variable reduction of caveolin-3 in patients with LGMD2B/MM.

Walter MC, Braun C, Vorgerd M, Poppe M, Thirion C, Schmidt C, Schreiber H, Knirsch UI, Brummer D, Müller-Felber W, Pongratz D, Müller-Höcker J, Huebner A, Lochmüller H. Walter MC, et al. Among authors: pongratz d. J Neurol. 2003 Dec;250(12):1431-8. doi: 10.1007/s00415-003-0234-x. J Neurol. 2003. PMID: 14673575

8

A newly identified chromosomal microdeletion and an N-box mutation of the AChR epsilon gene cause a congenital myasthenic syndrome.

Abicht A, Stucka R, Schmidt C, Briguet A, Höpfner S, Song IH, Pongratz D, Müller-Felber W, Ruegg MA, Lochmüller H. Abicht A, et al. Among authors: pongratz d. Brain. 2002 May;125(Pt 5):1005-13. doi: 10.1093/brain/awf095. Brain. 2002. PMID: 11960891

9

Skeletal muscle in children with congenital myotonic dystrophy in the first year of life.

Müller-Felber W, Schmidt-Achert M, Pongratz DE. Müller-Felber W, et al. Among authors: pongratz de. Clin Neuropathol. 1993 Jul-Aug;12(4):211-4. Clin Neuropathol. 1993. PMID: 8403631

10

A common mutation (epsilon1267delG) in congenital myasthenic patients of Gypsy ethnic origin.

Abicht A, Stucka R, Karcagi V, Herczegfalvi A, Horváth R, Mortier W, Schara U, Ramaekers V, Jost W, Brunner J, Janssen G, Seidel U, Schlotter B, Müller-Felber W, Pongratz D, Rüdel R, Lochmüller H. Abicht A, et al. Among authors: pongratz d. Neurology. 1999 Oct 22;53(7):1564-9. doi: 10.1212/wnl.53.7.1564. Neurology. 1999. PMID: 10534268

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

222 results

Search Page